The strategic partnership will establish a joint solution for the efficient creation of buffers created from concentrates delivered directly to manufacturing facilities, increasing productivity and ...

Nucleus Biologics launched the Krakatoa ® K500, which the company says is the first bioreactor-scale, pod-based media and buffer manufacturing system designed to deliver sterile solutions on demand ...

We listened to our customers’ frustrations with the complex process of centralized GMP liquid media manufacturing. With the Krakatoa® K500, we begin a journey to co-locate both media and buffer ...

Discover valuable insights for transforming your biopharmaceutical production with our comprehensive resource. We take a deep dive into the latest industry trend of outsourcing buffer and process ...

Helping pharmaceutical companies increase production efficiency and manage risk more effectively MOTIV is a buffer management technology for the vast majority of processes in pharmaceutical ...

The "Buffer Preparation Market Industry Trends and Global Forecasts to 2035: Distribution by Scale of Operation, Type of System Component, Type of Buffer Formulation, Type of Molecule, Type of ...

Discover how alternative buffer management strategies can reduce footprint, cut costs, and streamline downstream bioprocessing. Explore practical approaches, like buffer concentrates and stock ...

Helping pharmaceutical companies increase production efficiency and manage risk more effectively NEW YORK & CHICAGO--(BUSINESS WIRE)--Asahi Kasei Bioprocess America, subsidiary of diversified Japanese ...